Fig. 2

The prevalence of mildly reduced eGFR, normal eGFR and hyperfiltration according to obesity phenotype. The Bonferroni test was used for multiple comparisons among the four phenotypes, ^†P < 0.05, the prevalence of mildly reduced eGFR in MHO compared to MHNO; ^‡P < 0.05, the prevalence of hyperfiltration in MHO compared to MUNO; eGFR estimated glomerular filtration rate; MHNO Metabolically healthy non-obesity; MHO Metabolically healthy obesity; MUNO Metabolically unhealthy non-obesity; MUO Metabolically unhealthy obesity